John A. St.Cyr, MD, PhD

Cardiovascular Surgeon

Jacqmar, Inc

University of Minnesota, Minneapolis

Coon Rapids, Minnesota, USA


Biography

John A. St. Cyr, MD, PhD, a retired cardiovascular surgeon, received his B.A., BS, M.S., M.D., and Ph.D. degrees from the University of Minnesota, Minneapolis, MN. He completed his general surgical training at the University of Minnesota and completed his cardiovascular surgical fellowship training at the University of Colorado Health Sciences Center in Denver, CO. Dr. St.Cyr has extensive research credentials, is widely published, has received numerous local and national research grants, has numerous patents in various fields of interest, and has presented at both national and international meetings. Currently, Dr. St. Cyr has 17 issued patents, 12 patents pending, and numerous provisional patent submissions. Dr. St. Cyr has consulted for many medical companies, such as a surgical/medical consultant for Medtronic, Inc. (Physiological Research Laboratories, a facility of Medtronic, Inc., Minneapolis, MN), a medical/surgical consultant for NAMSA/Integra, Inc. (Minneapolis, MN), Chief Medical Officer for RCRI, Inc. (Minneapolis, MN), and ImmuMed, Inc. (Minneapolis, MN). Dr. St. Cyr is a member of numerous scientific research, medical, and surgical societies.

Research Interest

Scientific Activities

HONORS/AWARDS:
Summa Cum Laude (B.A., Physiology), University of Minnesota
Minnesota Surgical Society Research-Essay Award
Drs. R.L. Varco & J.E. Foker, Cardiovascular Scholarship
MERCK Award
Medical Student Research Award, Minnesota Medical Foundation, University of Minnesota
Phi Kappa Phi Honorary Society
Individual National Institute of Health Research Service/Fellowship Award
Minnesota Heart Association, Grant-in-Aid Research Award
Vikings Children's Fund, Grant-in-Aid Research Award, Co-investigator
Physician's Recognition Award, American Medical Association
Minnesota Heart Association, Grant-in-Aid Research Award
Physician's Recognition Award, American Medical Association
Physician's Recognition Award, American Medical Association
American College of Cardiology, Bristol Laboratories Affiliate Travel Award
Marquis Who's Who: West, Science and Engineering, America, World, Midwest, Medicine & Healthcare
Who's Who in American Inventors
International Who’s Who of Professionals
American Directory of Who’s Who in Executives and Businesses
Medtronic Inc., Technical Contributor of the Year Award (Aortic valve implant model)
America’s Registry of Outstanding Professionals
2000 Outstanding Scientists of the 21st Century (1st Edition)
Strathmore’s Who’s Who
Fellow, American Heart Association, Cardiovascular-Thoracic Surgical Division, FAHA
Fellow, International Biographical Association, FIBA
2000 Eminent Scientists of Today, International Biographical Association
Medtronic, Inc., Honorary Research Award (PRL), Advancing Medical Technology
Madison Who’s Who
Premier International Who’s Who of Outstanding Executives/Professionals, Honorary member

Publications

1. St.Cyr JA: "Measurable effects of hypoxia on the microvascular permeability in the isolated adult rabbit lung," Master's thesis, University of Minnesota, 1977.
2. Ward HB, Kriett J, St.Cyr JA, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Relationship between recovery of myocardial ATP levels and cardiac function following ischemia. J Am Coll Cardiol 3(2):544, 1984.
3. Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM, Foker JE: Enhanced recovery of ATP levels following global ischemia. Surg 96(2):248, 1984.
4. Foker JE, Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM: Enhanced ATP retrun after global ischemia. Eur Heart J 5(suppl):91, 1984.
5. St.Cyr JA, Bianco RW, Ascher NL, Foker JE: Consequences of ischemia on organ energy metabolism. Trans Proceed 17(1):1468, 1985.
6. Schneider J, St.Cyr JA, Thompson T, Johnson D, Burke B, Foker JE: The changing spectrum of cystic pulmonary lesions requiring surgical resection in infants. J Thorac Cardiovasc Surg 89(3):332, 1985.
7. St.Cyr JA, Braunlin E, Moller J, Ring WS, Molina JE, Foker JE: Management of pulmonary atresia and intact ventricular septum. J Am Coll Cardiol 5(2): 477, 1985.
8. Fath J, St.Cyr J, Constantinides F, Alden P, Ascher N, Bianco R, Foker J, Cerra F: Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes. Surg 98(3):396, 1985.
9. Einzig S, St.Cyr JA, Bianco RW, Schneider JR, Lorenz E, Foker JE: Myocardial ATP repletion with ribose infusion. Ped Res 19(4):127A, 1985.
10. Schneider JR, St.Cyr JA, Mahoney JR, Bianco RW, Ring WS, Foker JE: Recovery of ATP and return of function after global ischemia. Circ (Part II), 72(4):III_298, 1985.
11. St.Cyr JA, Shearen J, Delaney JD: New therapeutic approach for mixed anaplastic carcinoma of the thyroid. Minn Med 68(12):893, 1986.
12. St.Cyr J, Ward H, Kriett J, Alyono D, Einzig S, Bianco R, Anderson R, Foker J: Long term model for evaluation of myocardial metabolic recovery following global ischemia. In: Brautbar, N.(ed), Myocardial and Skeletal Muscle Bioenergetics, AEMB series. New York, NY, PLenum Publishing 194:401, 1986.
13. Bianco RW, St.Cyr JA, Rasmussen TM, Clack RM, Schneider JR, Shim HS, Sandstad J, Rysavy RB, Foker JE: Canine model for long term evaluation of prosthetic mitral valves. J Surg Res 41(2):134, 1986.
14. St.Cyr JA, Bianco RW, Foker JE, Noren G, Staley N, Wang TC, Einzig S: Myocardial high energy phosphate levels in cardiomyopathic turkeys. J Surg Res 41(3):256, 1986.
15. Kingsley_Hickman P, Sako EY, Andreone PG, St.Cyr JA, Michurski S, Foker JE, From AHL, Petein M, Ugurbil K: 31P NMR measurement of ATP synthesis in perfused intact rat hearts. J Fed Europ Biochem Soc 198(1):159, 1986.
16. St.Cyr JA, Ward HB, Kriett JM, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Long term model for evaluation of myocardial metabolic recovery following global ischemia. Adv Exp Med Biol 194:401, 1986.
17. Einzig S, St.Cyr J, Schneider J, Bianco R, Foker J: Maintained myocardial ATP with long term ribose. Ped Res 20(4),Part II:169A, 1986.
18. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, Ugurbil K, Foker JE: Dobutamine increases efficiency of ATP utilization in the post_ischemic isolated heart. Surg Forum XXXVII:236, 1986.
19. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, From AHL, Ugurbil K, Foker JE: Effect of ischemia and dobutamine on myocardial ATP production. Circ, Part II, 74(4):II_272, 1986.
20. St.Cyr JA, Thompson T, Johnson D, Ferrara TB, Foker JE: The diagnosis and treatment of gastroesophageal reflux in infancy. J Thorac Cardiovasc Surg 92(4):661, 1986.
21. Foker JE, Braunlin EA, St.Cyr JA, Moller JH, Ring WS, Molina JE: Management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg 92(4):706, 1986.
22. St.Cyr JA, Elick BA, Stock P, Freese D, Sharp H, Payne W, Bloomer J, Najarian J, Ascher N: Use of triple therapy and percutaneous needle biopsy to minimize rejection following liver transplantation. Trans Proceed 19(1):2451, 1987.
23. St.Cyr JA, Ward HB, Molina JE: Successful correction of a thoracic aortic aneurysm_bronchial fistula. J Card Surg 2:109, 1987.
24. St.Cyr JA, Bianco RW, Judd D, Pierpont ME, Staley N, Noren G, Foker JE, Einzig S: A new method of urine collection in turkeys and chickens. Lab Animal Sci 37:566, 1987.
25. Tveter KJ, St.Cyr JA, Bianco RW, Einzig S, Foker JE: Ribose enhanced recovery of diastolic function after global myocardial ischemia. Ped Res 23:226A, 1988.
26. St.Cyr JA: "Ribose enhanced recovery of myocardial ATP levels,"Ph.D. thesis, University of Minnesota, 1988.
27. St.Cyr JA, Lindberg E, Van Tassel R, Gannon PG: Contained rupture of an ascending aortic aneurysm with cystic medial necrosis, two years after blunt chest trauma. Contemp Surg 33(6):20, 1988.
28. St.Cyr JA, Jamieson SW: Heart lung transplantation. In: Martini N, Vogt_Moykopf I (eds): International Trends in General Thoracic Surgery. Thoracic Surgery: Frontiers and Uncommon Neoplasms. CV Mosby Co, St.Louis, Baltimore, Toronto, Vol 5:99, 1989.
29. St.Cyr JA, Schneider JR, Mahoney JR, Bianco RW, Tveter KJ, Einzig S, Foker JE: Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model. J Surg Res 45:157, 1989.
30. St.Cyr JA, Ferrara TB, Thompson T, Johnson D, Foker JE: Treatment of pulmonary manifestations of gastroesophageal reflux in children two years of age or less. Am J Surg 157:400, 1989.
31. Tveter K, St.Cyr J, Schneider J, Bianco R, Foker J: Enhanced recovery of diastolic function after global myocardial ischemia in the intact animal. J Am Coll Cardiol 13(2,A):130A, 1989.
32. Bensard DA, St.Cyr JA, Johnston MR: Acute pleuritic chest pain and lung mass in an elderly female. Chest 97(6):1473, 1990.
33. St.Cyr JA: Myocardial ischemia is irrelevant. In: Harken A (ed), Surgical Debates III, Philadelphia_Toronto, BC Decker Inc, Vol III:185, 1990.
34. Read R, St.Cyr JA, Tornabene S, Whitman GJ: Improved cannulation method for extracorporeal membrane oxygenation (ECMO). Ann Thorac Surg 50(4):670, 1990.
35. Durmowitz A, St.Cyr J, Clarke D, Stenmark K: Unilateral pulmonary hypertension as a result of chronic increased flow to one lung. Amer Rev Resp Dis 142(1):230, 1990.
36. Read R, St.Cyr J, Manek J, Whitman G, Hopeman A: Bronchial anomaly of the right upper lobe; a case report with a discussion of the literature. Ann Thorac Surg 50(6):980, 1990.
37. Fullerton DA, Kirson LE, St.Cyr J, Kennard T, Whitman GJR: Human pulmonary vascular resistance (PVR) is hydrogen ion not pCO2 sensitive. J Surg Res 49(4): 375, 1990.
38. Jones RL, St.Cyr JA, Tornabene SP, Lauber B, Harken AH: Reversible pulmonary hypertension secondary to mitral valvular disease as an indication for extracorporeal membrane oxygenation. Cardiovasc & Vasc Anesth 5(5):494, 1991.
39. Fullerton DA, St.Cyr J, Campbell DN, Clarke DR, Toews WH, See WM: The Bezold_Jarisch reflex in postoperative pediatric cardiac surgical patients. Ann Thorac Surg 52(3):534, 1991.
40. St.Cyr JA, Fullerton DA: Letter to the editor Aortic replacement with sutureless intraluminal graft. Texas Heart Instit J 18(2):144-45, 1991.
41. St.Cyr JA, Fullerton DA, Harken AH: Repair of the torn friable right atrium following decannulation. Ann Thorac Surg 52(6):1344, 1991.
42. Grosso MA, Banerjee A, St.Cyr JA, Rogers KG, Brown JM, Clarke DR, Harken AH: Cardiac 5'_nucleotidase increases with age and inversely relates to recovery from ischemia. J Thorac Cardiovasc Surg 103(2):206-209, 1992.
43. St.Cyr JA, Bolman III RM, Foker JE: Cardiac transplantation following the modified Fontan procedure. Editorial. Trans Sci 2(1):3, 1992.
44. St.Cyr JA, Campbell DN, Fullerton DA, Grosso M, Bishop DA, Clarke DR: Cryoperserved allograft repair of aortic hypoplasia-interrupted aortic arch. Ann Thorac Surg 53(6):1110, 1992.
45. St.Cyr JA, Fullerton DA: Successful repair of a pseudoaneurysm, originating from a true left ventricular aneurysm. Am Heart Jour 124(5):1381, 1992.
46. DeMarco C, Alonso K, Nardi C, Pontiggio P, Mathe G, Zablow A, St.Cyr J, Shecterle L: Hyperthermia: An effective AIDS treatment. PWA Coalition Newsline 86:17-21, 1993.
47. Irwin E, Clack R, Lang G, St.Cyr J, Runge W, Foker J, Bianco R: Long term evaluation of prosthetic mitral valves in sheep. J Invest Surg 6(2):133, 1993.
48. Fullerton DA, Kirson L, St.Cyr JA, Kinnard T, Whitman GJR: Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation. J Thorac Cardiovasc Surg 106(3):528, 1993.
49. Fullerton DA, Kirson LE, St.Cyr JA, Albert JD, Whitman GJR: The influence of respiratory acid-base status of adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 103(4):1091, 1993.
50. Esper E, Krabill KA, St.Cyr JA, Patton C, Foker JE: Repair of multiple mycotic aortic aneurysms in a young infant with reviewof the literature. J Ped Surg 28(12):1553, 1993.
51. St.Cyr JA: US Patent, “Suture Removal Device,” #5250052, 1993.
52. St.Cyr JA: Who’s Who of American Inventors, 1994-95 edition, page 142, 1994.
53. St.Cyr JA, Shecterle LM: Low flow extracorporeal hyperthrmia treatment in HIV infected patients with Kaposi's Sarcoma, Phase I clinical protocol, copyrighted 1993, 1996.
54. Fullerton DA, St.Cyr JA, Albert JA, Grover FL: Hemodynamic advantages of left atrial epinephrine administration after cardiac operations. Ann Thorac Surg 56(6):1263, 1993.
55. Shecterle LM, St.Cyr JA: Does hyperthermia have a therapeutic role in HIV disease? J Minnesota Acad Sciences 58(2):27-30, 1994.
56. Shecterle L, St.Cyr J: Extracorporeal whole body hyperthermia as a treatment option in HIV/AIDS disease, "Low flow technique," Feasibility clinical study, clinical instruction manual, Copyright-Organetics, Ltd., 1994.
57. St. Cyr JA, Fullerton DA, Zamora M, Hopeman AR: Tracheobranchial disruption: postoperative management with jet ventilation to minimize airway pressure. J Cardiovasc Surg 35(1):79-81, 1994.
58. Fullerton DA, St. Cyr JA, Fall SM, Whitman GJ: Protection of the patent internal mammary artery by-pass graft from subsequent sternotomy. J Cardiovasc Surg 35(6):499-501, 1994.
59. Fullerton DA, Kirson LE, St.Cyr JA, Albert JD, Whitman GJR. The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Year book of Critical Care Medicine, Rogers M (ed.), Mosby Year Book, Inc., Chicago, Il, 1994.
60. St.Cyr JA, Shecterle LM: Effects of hypoxia on pulmonary microvascular permeabilibty in the isolated adult rabbit lung. J Biomed Sci 2(1):70-76, 1995.
61. Shecterle LM, Gasper P, St.Cyr JA: Current and future prospects of whole body hyperthermia for deactivation of HIV. J AIDS Patient Care 9(2):85, 1995.
62. Shecterle LM, Kelly T, St.Cyr JA: Therapy with extracorporeal whole body hyperthermia. Abstract, Serono Symposia: Idea to product. November, 1994, Washington, D.C., Abstract booklet.
63. Shecterle LM, Kelly T, Zablow A, St.Cyr JA: Altered lipid metabolism with hyperthermia. FASEB Journal 9(4):A646, 1995.
64. Shecterle LM, Gasper PW, St.Cyr JA: Hyperthermia as a potential treatment in HIV disease. Alternative Medicine Journal 2(3):28-32, 1995.
65. Shecterle LM, St.Cyr JA: Letter to the editor, Localized or systematic in vivo heat-inactivation of human immunodeficiency virus (HIV); a mathematical analysis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(3):391, 1995.
66. Shecterle LM, St.Cyr JA: Rate of temperature rise using a hot air whole body hyperthermia device. Southern Med Journal 88(10): PS142, PS143, 1995.
67. Shecterle LM, Gasper PW, St.Cyr JA: Potential role of using whole body hyperthermia to treat Lyme disease. Southern Med Journal, 88(10): PS142, 1995.
68. Shecterle LM, Kelly T, St.Cyr JA: Canine Experimentation with low flow extracorporeal whole body hyperthermia. Southern Med Journal 88(10): PS143, 1995.
69. Shecterle LM, Gasper PW, St.Cyr JA: Could whole body hyperthermia have a role in the treatment of Lyme disease? Alternative Medicine Journal 2(4):19-20, 1995.
70. Shecterle LM, St.Cyr JA: Whole Body Hyperthermia as a Potential Therapeutic Option, Invited submission. Cancer Biotherapy 10(4):253-256, 1995.
71. Zablow A, Dorian R, Kelly T, St. Cyr JA: Feasibility trial using extracorporeal whole body hyperthermia in AIDS patients. J Investigative Medicine 44(1):192A, 1996.
72. Henry K,Erice A, Balfour H, Beatty C, St. Cyr JA: Acute effects of whole body hyperthermia on plasma HIV-RNA levels. Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, p. 26 Abstr 373, 1996.
73. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 1:261, 1996.
74. St.Cyr, JA: Medical Minute....Hyperthermia. Medcorp News 5(second quarter):2, 1996.
75. Fullerton DA, McIntyre RC, Kirson LE, St.Cyr JA, Whitman GJR, Grover FL: Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 61:696-701, 1996.
76. St.Cyr JA, Kelly T, Shecterle LM: Cranial venous effluent temperature assessment during extracorporeal whole body hyperthermia. FASEB Journal 10(3):A118, 1996.
77. Shecterle LM, Kelly T, Dorian R, St.Cyr JA: Maintenance of renal and hepatic function with dopamine during and following extracorporeal whole body hyperthermia. FASEB Journal 10(3):A119, 1996.
78. Shecterle LM, Kelly T, St.Cyr JA: Letter to the Editor, Safe and efficient method of inducing whole body hyperthermia. International Journal of Hyperthermia 12(4):569-571, 1996.
79. St.Cyr JA, Kelly T, Shecterle LM: Whole Body Extracorporeal Low Flow Hyperthermia in a Canine Model. J Extracorporeal Technology 28(3):140-146, 1996.
80. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 2:275-277, 1996.
81. Zablow A, Dorian R, Myers R, Holton M, Kelly T, Shecterle L, St.Cyr J: Use of low flow extracorporeal whole body hyperthermia in the treatment of HIV disease, a feasibility study. Southern Med J 89(10):S150-51, 1996.
82. Shecterle LM, St.Cyr JA: The effects of radiant rewarming on pH (corrected vs uncorrected) in severely hypothermic canines. FASEB Journal 2:A526, 1997.
83. Shecterle LM, Kelly T, St.Cyr JA: Response, Letter to the Editor, “Safe and efficient method for inducing whole body hyperthermia.” International J Hyperthermia 13(3):339-340, 1997.
84. Shecterle LM, St.Cyr JA: A further comment on alternative HIV therapies. The Scientist 11(9):10, 1997.
85. Zablow A, Shecterle L, Dorian R, Kelly T, Fletcher S, Forman M, Sanfilippo L, St.Cyr J: Extracorporeal whole body hyperthermia treatment in HIV patients, a feasibility study. Int J Hyperthermia 13(6):577-586, 1997.
86. Shecterle LM, St.Cyr JA: Hyperthermia in Medicine. Proc 4th Int Symposim on Biol Closed Elect Circuits, pp 286-289, 1997.
87. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia alters HIV kinetics, Results of a study. Alternative Therapies in Clinical Practice 4(5):162-164, 1997.
88. Shecterle LM, St.Cyr JA: Twelve month follow up in advanced HIV patients treated with whole body hyperthermia. Onkologie, J of Oncology 29(suppl 4a):12, 1997.
89. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia affects complement levels. J Investigative Medicine 46(1):50A, 1997.
90. Shecterle LM, St.Cyr JA: Potential resolution of Zidovudine (AZT) anemia. J Investigative Medicine 46(1):65A, 1997.
91. Shecterle,LM, St.Cyr JA: Radiant rewarming for hypothermia: pilot canine study model. Journal Minnesota Academy of Science 62(1):12-16, 1997.
92. Shecterle LM, St.Cyr JA: US Patent, “Double Layer Prophylactic Incorporating Pharmacological Fluid and Spiral Barrier Layer,” #5623945, 1997.
93. Myers R, Holton M, Kelly T, St.Cyr J, Dorian R, Cavanaugh L: The use of extra corporeal whole body hyperthermia in HIV/AIDS patients. Abstract, AMSECT meeting, 1998.
94. Shecterle LM, Clark L, St.Cyr JA: Metastatic prostate cancer treated with whole body hyperthermia: a case report. J Investigative Medicine 46(3):242A, 1998.
95. Zablow A, Shecterle LN, Kelly T, St.Cyr JA: Response to the letter to the Editor:Hyperthermia and AIDS: a Critical Review. Int J Hyperthermia 14(4):419, 1998.
96. St.Cyr J, Wetherall, N, Wernes L, Shecterle L, Blick G, Greiger P: HIV is heat sensitive In Vitro. FASEB Journal 47(4):210A, 1999.
97. Rakow N, Nelson D, Boldt C, Pfenning K, McClay C, Waskiewicz J, Shecterle L, St.Cyr J: Chronic orthotopic aortic valve implantation model. Proceedings from the World Symposium on Heart Valve Disease. London, UK, page 188, 1999.
98. Shecterle L, Zablow A, Kelly T, St.Cyr J: Abnormal cervical histopathology reversed with whole body hyperthermia. FASEB Journal 47(4):208A, 1999.
99. Shecterle LM, St.Cyr JA: Response to a Letter to the Editor, “More on Hepatitis C,” The Scientists 13(11):12, 1999.
100. St.Cyr JA, Rakow NJ, Nelson DA, Pfenning KA, Boldt CW, McClay CB: Chronic model for aortic valve replacement. Medtronic’s, 10th Annual Science and Technology Conference, Abstract booklet, page 18, 1999.
101. Shecterle LM, Wetherall NT, St.Cyr JA: Effects on C3 and CH50 levels during and following extracorporeal whole body hyperthermia. J Extracorporeal Technology 31(4):191-4,1999.
102. Rakow N, Nelson D, Boldt C, Pfenning K, McClay C, Waskiewicz J, Shecterle L, St.Cyr J: Chronic orthotopic aortic valve implantation model. J Heart Valve Disease 9(6):822-8, 2000.
103. Shecterle LM, St.Cyr JA: Reversal of cervical dysplasia with hyperthermia. Letter to the Editor.
International J Hyperthermia 16(5):443-444, 2000.
104. Shecterle L, Rakow N, Waskiewicz J, Nelson D, Boldt C, St.Cyr J: Dobutamine stress evaluation of the Medtronic Advantage aortic prosthesis. FASEB Journal 14(4):A154. 2000.
105. Shecterle L, Holton M, Myers R, Zablow A, St.Cyr J: Delay in normalization of hematologic parameters following extracorporeal whole body hyperthermia. FASEB Journal 14(4):A87, 2000.
106. Vance R, Einzig S, Kreisler K, Shecterle L, St.Cyr J: D-Ribose maintains ejection fraction following aortic valve surgery. FASEB Journal 14(4):A419, 2000.
107. St.Cyr J, Johnson C: Composition for increasing energy in vivo. Patent #6159942, 2000.
108. Butler T, St.Cyr J: Use of ribose to prevent cramping and soreness in muscles. Patent #6159943, 2000.
109. Shecterle L, Grangaard R, Hudak J, Rakow N, Nelson D, St.Cyr J: Anesthetic management in sheep undergoing prosthetic valve implantation. FASEB Journal 15(5), Part 2:A1137, 2001.
110. Seifert JG, Frelich A, St.Cyr J: The toxicological effects of 14 days of ribose ingestion. FASEB Journal 15(5), Part 1:B392, 2001.
111. Illien S, Omran H, Mac Carter D, St.Cyr J: Ribose improves myocardial function in
congestive heart failure. FASEB Journal 15(5), Part 2:A1142, 2001.
112. Illien S, Omran H, Mac Carter D, St.Cyr J: Ribose improves myocardial function and quality of life in congestive heart failure patients. J Mol Cell Cardiol 33(6):A173, 2001.
113. Ericson D, Karnicki K, Shecterle LM, St.Cyr J, Rao G: Viacyte enhances functional parameters in stored platelets. Blood (suppl) 98(11):4057 (abst 104B), 2001.
114. Sawada S, St.Cyr J, Johnson CA: Method for determining viability of a myocardial
segment, #6339716, 2001.
115. St.Cyr J, Johnson C, Mac Carter D, Sawada S: Method for raising the hypoxic threshold, patent, #6218366, 2001.
116. Ericson D, Shecterle LM, St.Cyr J: D-Ribose maintains spermatocyte motility- a case report. FASEB journal 16(5), Part II:A781,2002.
117. Ericson D, St.Cyr J: Ehanced platelet function and extended eight day storage using new platelet preservative solution. Vox Sang 83 (Suppl 2): Abstr #023, page 9, 2002.
118. Ericson D, Karnicki K, Johnson C, St.Cyr J, Rao GHR: A new platelet preservative. Platelets 13(7): 431-32, 2002.
119. St.Cyr J, Johnson C, Hagerman S, Vasquez L, Butler T: Compositions for increasing athletic performance in mammals, Patent #6429198, 2002.
120. Rakow N, Nelson D, McClay C, Rose R, Leuer L, Boldt C, Shecterle L, St.Cyr J: Assessment of the Medtronic Advantage™ Aortic Valve Prosthesis. JHVD 11(6):851-856, 2002.
121. Wilson R, Johnson C, Mac Carter D, St.Cyr J: Ribose enhances the identification of hibernating myocardium. Heart Drug 3(1):61-2, 2003.
122. Shecterle L, Browdie D, St.Cyr J: Non-gluteraldehyde surgical adhesive. FASEB Journal 17(5):A937, 2003.
123. Pauly D, Johnson C, St.Cyr J: The role of ribose in cardiovascular disease. Med Hypoth 60(2):149-151, 2003.
124. Rakow N, Grangaard R, Allen N, Shecterle L, St.Cyr J: Aortic root replacement model in adult sheep. Medtronic’s Second Animal Model symposium, Page 11, 2003.
125. Fernholz KM, Seifert JG, Shecterle LM, St.Cyr JA: RiboGro enhances rooting development. J MN Acad Sci 67(1):29, 2003.
126. Omran H, Illien S, MacCarter D, St.Cyr J, Luderitz B: D-ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur J Heart Fail 5(5):615-9, 2003.
127. Butler T, St.Cyr J, Johnson C: Method for treating acute mountain sickness, Patent #6511964, 2003.
128. Ericson D, Lien S, Morari F, St.Cyr J, Adcock D: Ribose preserves aggregation in apheresis platelets. Blood 102(11):p63B, 2003.
129. Karnicki K, Johnson C, St.Cyr J, Ericson D, Rao G: Platelet storage solution improves the in vitro function of preserved platelet concentrates. Vox Sanguinis 85(4):262-266, 2003.
130. Percival S, Henken R, St.Cyr J, Johnson C, Butler T: Compositions for enhancing the immune response, Patent #6663859, 2003.
131. St.Cyr J, Johnson C: Compositions for increasing energy in vivo, Patent #6534480, 2003.
132. St.Cyr JA, Holton JM, Kelly TC, Shecterle LM: Dual lumen adjustable length cannulae for liquid perfusion or lavage, Patent #6692473, 2004.
133. Shecterle LM, Nelson D, Billstrom T, Passenheim J, Lieb C, Rakow N, St.Cyr J: Platelet gel/felt aids in hemostasis in total aortic root replacement in adult sheep. FASEB journal 18(5), Part II:A1302, 2004.
134. Falkner P, Millner H, Wahlberg P, Nelson D, Billstrom T, Shecterle L, Rakow N, Lieb C, St.Cyr J: Correlation of pre-operative and intra-operative echocardiographic assessment of the aortic valve annulus in adult sheep. FASEB journal 18(5), Part II:A1303, 2004.
135. Dodd S, Johnson C, Fernholz K, St.Cyr: The role of ribose in human skeletal muscle metabolism. Medical Hypotheses 62(5):819-824, 2004.
136. Omran H, Mac Carter D, St.Cyr J, Luderitz B: D-ribose aids congestive heart failure patients. Experimental and Clinical Cardiology 9(2):117-118, 2004.
137. Ericson D, St. Cyr J: Compositions for the storage of platelets, patent #6790603, 2004.
138. Falkner P, Millner H, Wahlberg P, Nelson D, Billstrom T, Shecterle L, Rakow N, Lieb C, St.Cyr J: Correlation of pre-operative and intra-operative echocardiographic assessments of the aortic valve annulus in adult sheep. 23rd Annual Scientific and Technology conference, Medtronic, Inc. , Proceedings, p. 335, 2004.
139. Nelson D, Rakow N, Falkner P, Lieb C, Billstrom T, Grangaard R, Hammargren J, Alfson L, Shecterle L, St.Cyr J: Chronic orthotopic total aortic root replacement sheep model. 23rd Annual Scientific and Technology Conference, Medtronic, Inc., Proceedings, p. 305, 2004.
140. Perkowski D, Wagner S, Marcus, A, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. 2nd place prize, Proceedings from the Scripps Natural Supplement Conference, La Hoya, CA, Jan, 2005.
141. St.Cyr JA, Passwater R: Interview with Dr. Passwater. Interview Vitamin Connection: Ribose. Whole Foods Magazine, pp.45-47, 2005.
142. Perkowski D, Wagner S, Marcus A, Johnson C, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. Proceedings from New Era Cardiac Care 2005, p. 52, 2005.
143. Alfson L, Rakow N, Nelson D, Wahlberg P, Shecterle L, St.Cyr JA: Novel Chest Tube Circuitry. FASEB J (Part 1) 19(4):A636, 2005.
144. Perkowski D, Wagner S, Marcus A, St.Cyr J: Pre-surgical loading of oral D-Ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. FASEB J (Part 1) 19(4):A695, 2005.
145. Sharma R, Munger M, Litwin S, Vardeny O, MacCarter D, St.Cyr J: D-ribose improves Doppler TEI myocardial performance index and maximal exercise capacity in stage C heart failure. JMCC 38(5):853, 2005.
146. Vijay N, MacCarter D, Washam M, St.Cyr J: Ventilatory efficiency improves with D-ribose in congestive heart failure. JMCC 38(5):820, 2005.
147. Perkowski D, Wagner S, Marcus A, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. J Altern & Compl Med 11(4): 745, 2005.
148. Lemmon J, Nelson D, Rakow N, Barka N, Allen N, St.Cyr J: Transcatheter percutaneous pulmonary valve implantation in adult sheep: Model development. Proceedings from Medtronic’s 2nd Animal Model Symposium, June, 2005.
149. Lemmon J, Nelson D, Rakow N, Barka N, Allen N, St.Cyr J: Transcatheter percutaneous pulmonary valve implantation in adult sheep: model development. Proceedings from the third biennial meeting of The Society for Heart Valve Disease, abstract # P134, p335, 2005.
150. Falkner P, Millner H, Nelson D, Rakow N, Shecterle LM, St.Cyr JA: Transthoracic echocradiographic technique for aortic valve annular determination in adult sheep undergoing prosthetic valve implantation. OJVR 9(2):83-94, 2005.
151. Vijay N, Mac Carter D, Washam M, Munger M, St.Cyr J: D-ribose improves ventilatory efficiency in congestive heart failure patients (NYHA classes II-IV). J Card Fail 11(6):abst 019,S95, 2005.
152. Johnson C, St.Cyr J: Letter to the Editor. Ribose preserves ventricular function following aortic valve surgery. Internet J of Thor and CV Surg, 7(2): Letter to the Editor, 2005.
153. Johnson C, Mac Carter D, St.Cyr J: Letter to the Editor. Recovery of depressed myocardial energy levels. Internet J of C-V Res, 2(2): Letter to the Editor, 2005.
154. Johnson C, St.Cyr J: Letter to the Editor. Ribose preserves ventricular function following aortic valve surgery. Internet J of C-V Res, 2(2): Letter to the Editor, 2005.
155. Alfson L, Rakow N, Nelson D, Shecterle L, St.Cyr J: Chest tube drainage circuitry in mammals. Vet Surg 34(5):537, 2005.
156. Shecterle LM, St.Cyr JA: It’s Payback Time, Letter to the editor, Phi Kappa Phi Forum, Winter/Spring, 86(1):40, 2005-06.
157. Shecterle LM, St.Cyr JA: A novel therapeutic approach to advanced lung cancer. The Int J Oncol 3(1), 2005.
158. St.Cyr JA: Corvalen M-Your natural supplement for restoring energy. NFA Fibromyalgia Online, 5(16): 2005.
159. St.Cyr J: Condition Specific Nutrition: CORvalen M. Total Health, 27(5):27, 2005.
160. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. Proceedings of the Am Thor Soc, 3 (Abstract issue):A651, 2006.
161. Vijay N, Mac Carter D, Washam M, St.Cyr J: D-ribose benefits low level exercise in advanced class CHF patients. J Card Fail 12(6), Suppl: #401,S122, 2006.
162. Shecterle LM, Vertress, R, Zwischenberger J, St.Cyr JA: Hyperthermia aids patients with advanced lung cancer, editorial. Society for Thermal Medicine, 2006 Annual Meeting Program and Abstract Proceedings, p. 56, 2006.
163. Rakow N, Nelson D, Falkner P, Wahlberg P, Grangaard R, Capps M, Billstrom T, Shecterle LM, St. Cyr JA: Orthotopic total aortic root replacement model in adult sheep. J Invest Surg 20(1):55-59, 2007.
164. Teitelbaum JE, Johnson C, St.Cyr JA: The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Alt & Comp Med 12(9):857-862, 2006.
165. Griffiths JC, Borzelleca JL, St.Cyr J: Sub-chronic (13 week) oral toxicity study with D-ribose in Wistar rats. J Food and Chem Tox 45(1):144-152, 2007.
166. Griffiths JC, Borzelleca JL, St.Cyr J: Lack of oral embryotoxicity/teratogenicity with D-ribose in Wistar rats. J Food and Chem Tox 45(3):388-395, 2007.
167. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose improves cardiac indices in patients undergoing “off” pump coronary arterial revascularization. J Surg Res 137(2):295, 2007.
168. Teitelbaum J, St.Cyr J, Johnson C: Effective treatment of chronic fatigue syndrome and fibromyalgia with D-ribose. Syllabus, International Association for Chronic Fatigue Syndrome (IACFS/ME) meeting, fatigue section, 2007.
169. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, St.Cyr J, Rakow N, Barka N, Billstrom T: In-vivo motion of mitral valve annuloplasty devices. Proceedings from Medtronic, Inc.’s 25th Annual S&T Conference, 2006.
170. Griffiths J, St.Cyr J: D-ribose has non-significant toxicity in both short and long term supplementation. The Toxicologist 96(S-1):p. 299, 2007.
171. Borel M, Calmon E, Bezivin C, Pletsch S, St.CyrJ: D-ribose enhances basal and mitochrondrial respiratory rates in human dermal fibroblasts. FASEB journal, 21(6):A835, 2007.
172. Perkowski D, Wagner S, St.Cyr J: D-ribose benefits “off” pump coronary artery bypass revascularization. J Card Surg 22(4):370-371, 2007.
173. Rakow N, Barka N, Nelson D, Allen N, Gringaard R, Falkner P, Wahlberg P, Lemmon J, Phillips L, Billstrom T, Hill A, Shecterle L, St.Cyr J: Right ventricular outflow tract reconstruction model in adult sheep for placement of the Melody transcatheter pulmonary valve. J Invest Surg 20(3):187-193, 2007.
174. Redmond J, Christiansen D, Bergin C, Ryan T, Rakow N, Barka N, St.Cyr J, Grossi E: In vivo motion of mitral valve annuloplasty devices. The Society for Heart Valve Disease, 4th Biennial Meeting, June 2007, abstract #13.
175. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, Rakow N, Barka N, Billstrom T, Shecterle L, St.Cyr J, Grossi E. Differences in mitral valve annular function under full and partial ring annuloplasty. J Heart Disease 5(1):abst #615, p 154m 2007, 13th World Congress on Heart Disease.
176. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose and “off” pump coronary artery bypass revascularization aids in cardiac indices following acute myocardial infarction. J Heart Disease 5(1):abst #366, p 92, 2007, 13th World Congress on Heart Disease.
177. Lamberts RR, Caldenhoven E, Lansink M, Witte G, St.Cyr JA, Stienen GJM: D-ribose/folic acid aids right ventricular diastolic function in induced pulmonary hypertension. J Heart Disease 5(1):abst #255, p 64, 2007, 13th World Congress on Heart Disease.
178. Lamberts RR, Caldenhoven E, Lansink M, Witte G, Vaessen RJ, St.Cyr JA, Stienen GJM. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy. Am J Physiol: Heart Circ Physiol 102(1):19-27, 2007.
179. MacCarter D, Shecterle LM, St.Cyr JA. D-Ribose benefits COPD. Internet J Pulm Med 7(2), 2007.
180. MacCarter D, Miller F, Sierminski H, St.Cyr J, Vijay N. VV optimization improves breathing and oxygen uptake efficiency. J Card Fail 13(6): page S188, 2007.
181. MacCarter D, Vijay N, Sierminski H, Anderson S, St.Cyr J. Muti-Parameter Index (MPI), Sub-Maximal heart and lung based risk scores for heart disease. J Card Fail 13(6):page S188, 2007.
182. Redmond J, Christiansen D, Bergin C, Leur L, Ryan T, Rakow N, Barka N, Billstrom T, Shecterle L, St.Cyr J. Differences in mitral valve annular function under full and partial ring annuloplasty. Recent Advances in Cardiovascualr Disease. Proceedings of the 13th World Congress on Heart Failure. Medimond Publishing, Bologna, Italy, pp 457-460 (H728C0309), 2008.
183. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, Rakow N, Barka N, Billstrom T, St.Cyr JA, Shecterle LM, Grossi E. In-vivo motion of mitral valve annuloplasty devices. JHVD 17(1):110-118, 2008.
184. St.Cyr JA. Energy for the heart: D-ribose supplementation can boost and restore myocardial metabolism. Advances in Healthy Aging 3(4):47-48, 2007.
185. Vijay N, MacCarter D, Shecterle LM, St.Cyr JA. Letter to the Editor. D-ribose benefits heart failure patients. J Med Food 11(1):199-200, 2008.
186. Fullerton DA, St.Cyr JA. Letter to the Editor. Mixed venous oxygen saturation in the diagnosis of cardiac tamponade. J Card Surg 23(2):180-181, 2008.
187. Perkowski D, Wagner S, St.Cyr J. D-ribose and “off” pump coronary artery bypass revascularization aids cardiac indices following acute myocardial infarction. Proceedings from the 11th Annual New Era Cardiac Care: Innovation and Technology. San Diego, 2008.
188. Fenstad ER, Gazal O, Shecterle LM, St.Cyr JA, Seifert JG. Dose effects of D-ribose on glucose and purine metabolites. The Internet Journal of Nutrition and Wellness 5(1), 2008.
189. Sperduto CM, St.Cyr J, Papermaster Bender G, Sperduto P. A prospective randomized clinical trial of ribose in patients with advanced cancer: An analysis of oxygen saturation and fatigue. Oncology 22(4), supplement 1:p21, 2008.
190. Perkowski DJ, Wagner SL, St.Cyr JA. D-ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. JMCC 44(6, Supplement )1:S5-6, 2008.
191. Seifert J, Frelich A, Shecterle L, St.Cyr J. Assessment of hematological and biochemical parameters with extended D-ribose ingestion. J Int Soc Sports Nutr 5(1):13, 2008.
192. Freeman ML, Mertens-Talcott S, St.Cyr J, Percival SS. Ribose enhances retinoic acid-induced differentiation of HL-60 cells. Nutr Res 28(11):775-782, 2008.
193. Herrick J, St.Cyr J. Ribose in the Heart. J Dietary Supplements 5(2):213-217, 2008.
194. Shecterle L, Kasubick R, St.Cyr J. D-ribose benefits Restless Legs Syndrome. J Alt & Comp Med 14(9):1156-66, 2008.
195. St.Cyr JA, Schneider JR. Letter to the Editor. A Sugar that benefits Failing Hearts. Internat J Card 131(3):398, 2009.
196. MacCarter D, Flannigan R, Washam M, Shecterle LM, St.Cyr J. D-ribose improves fatigue in adults. J Alt & Comp Med 15(7):812, 2009.
197. Sawada SG, Lewis S, Kovacs R, Khouri S, Gradus-Pizlo I, St.Cyr J, Feigenbaum H. Evaluation of the anti-ischmic effects of D-ribose during dobutamine stress echocardiography: a pilot study. Cardiovasc Ultrasound 7(5):7120-7, 2009.
198. Herrick J, Shecterle LM, St.Cyr JA. D-ribose–an additive with caffeine. Medical Hypotheses 72(5):499-500, 2009.
199. Butler T, St.Cyr J, Johnson C. Composition methods for improving cardiovascular function. Patent, #7553817, 2009.
200. Wagner S, Herrick J, Shecterle LM, st.Cyr JA. D-ribose, A metabolic substrate for congestive heart failure. Prog Cardiovasc Nurs 24:59-60, 2009.
201. Seifert JG, Subudhi AW, Fu MX, Riska KL, John JL, Shecterle LM, St.Cyr JA. The role of ribose on oxidative stress during hypoxic stress: A pilot study. J Med Food 12(3):690-693, 2009.
202. MacCarter D, Vijay N, Washam M, Shecterle LM, Sierminski H, St.Cyr JA: Letter to the Editor. D-ribose Aids Advanced Ischemic Heart Failure Patients. Internat J Card, 137(1):79-80, 2009.
203. Kopcak M, Leet C, Rakow N, Barka N, St.Cyr J. Dual arterial cannulation for aortic surgical procedures in adult sheep. 28th Annual Science and Technology Conference, Medtronic Inc., 2009.
204. Shecterle LM, St.Cyr JA. Dermal benefits of topical D-ribose. Clinical, Cosmetic and Investigated Dermatology, 2:151-152, 2009.
205. Wagner S, Shecterle L, St.Cyr J. A simple 5-carbon sugar which has potential as a metabolic substrate for congestive heart failure. Proceedings from the 8th International Congress on Coronary Artery Disease: From prevention to intervention. Abstract #1152, 2009.
206. Perkowski D, Wagner S, Shecterle L, St.Cyr J. Off-pump coronary artery bypass with a metabolically directed protocol with D-ribose. Proceedings from the 8th International Congress on Coronary Artery Disease: From prevention to intervention. Abstract #1153, 2009.
207. Flanigan R, MacCarter D, Shecterle L, St.Cyr J. D-ribose aids fatigue in aging adults. Letter to the Editor. J Alt & Comp Med;16(5):529-530, 2010.
208. Brookman R, St.Cyr J. Metabolic supplementation with enhanced external counterpulsation improves myocardial function in acquired cardiomyopathy: A case report. J Alt & Comp Med 16(3):323-325, 2010.
209. Wagner SL, Schneider JR, St.Cyr JA, Perkowski DJ. A metabolic approach for “off pump” coronary artery bypass. Proceedings from the American College of Surgeons, Southern California Chapter meeting, 2010.
210. St.Cyr J, Ericson D, Johnson C. Rejuvenation of stored blood, Patent USP7687468, 2010.
211. Shecterle LM, Terry KR, St.Cyr JA. The patented uses of D-ribose in cardiovascular diseases.
Recent Pat Cardiovasc Drug Dis. 5(2):138-42, 2010.
212. Shecterle L, St.Cyr J. Letter to the Editor. Nutraceuticals aid dermal fibroblasts. The Internet Journal of Nutrition and Wellness 9(2), 2010.
213. Shecterle LM, St.Cyr JA. Case Report. Visual success following complications from multiple retinal detachments. The Internet Journal of Ophthalmology and Visual Science 7(2), 2010.
214. Shecterle LM, St.Cyr JA. High strength biocompatible hemostatic tissue adhesive. Proceedings from the North Atlantic Treaty Organization (NATO) symposium, “Use of advanced technologies and new procedures in medical field operations,” Essen, Germany; p25, 2010.
215. Kocheril A, St.Cyr JA, MacCarter D. The importance of cardiopulmonary exercise testing. Eur Heart J, E-letter online, May 14, 2010.
216. Kopcak M, Barka N, Rakow N, Leet C, Shecterle L, St.Cyr J. Dual arterial cannulation for aortic surgical procedures in adult sheep. Eur Surg Res 45(1): 9-12, 2010.
217. Seifert J, Shecterle L, St.Cyr J. Supplements for exercise. Commentary. J Dietary Supplements 7(4):414-416, 2010.
218. MacCarter D, Kocheril A, Flanigan R, St.Cyr J. Assessing diastolic dysfunction. Letter to the Editor. Internat J Card 145(3):610, 2010.
219. Barka N, Kopcak M, Kelly T, Schendel M, Hill A, Grangaard R, Allen N, Shecterle L, St.Cyr J. Pressure load sensing assessments of the right ventricular outflow tract and main pulmonary artery. Surgical Technique. J Invest Surg 24(2):77-80, 2010.
220. Shecterle LM, St.Cyr JA. Metabolic energy changes during exercise in equines. Veterinary Medicine: Research and Report 2010(1):1-2, 2010.
221. Shecterle LM, Wagner S, St.Cyr JA. A sugar for congestive heart failure patients. Ther Adv Cardiovasc Dis 5(2):95-97, 2011.
222. Perkowski D, Wagner S, Schneider JR, St.Cyr JA. A targeted metabolic protocol with D-ribose for off pump coronary artery bypass procedures: A retrospective analysis. Ther Adv Cardiovasc Dis 5(4):185-192, 2011.
223. Foker J, Berry J, Harvey B, Befera N, Tveter K, St.Cyr J, Bianco R. Heart failure is initiated by and progresses because of normal responses of energy metabolism to stress. Circ Res , 2011.
224. Rakow N, Barka N, Gerhart R, Rothstein P, Green M, Schu C, Grassl E, St.Cyr JA, Kopcak MW, Jr. Chronic aortic root pressure-loading assessment model. J Invest Surg 25(2):137, 2012.
225. Shecterle LM, St.Cyr JA. Chapter 11; Myocardial Ischemia: Alterations in myocardial cellular energy and diastolic function, a potential role for D-ribose. In: Novel Strategies in Ischemia Heart Disease. Lakshmanadoss U(Ed). InTech, Croatia. 219-228, 2012.
226. Addis P, Shecterle LM, St.Cyr JA. Cellular protection during oxidative stress: a potential role for D-ribose and antioxidants. Journal of Dietary Supplements 9(3):178-182, 2012.
227. Holsworth R, Shecterle L, St.Cyr J, Sloop G. Letter to the Editor. Importance of monitoring blood viscosity during cardiopulmonary bypass. Perfusion 28(1):91-2, 2013.
228. Seifert JG, McNair M, DeClercq P, St.Cyr JA. A heat and moisture mask attenuates cardiovascular stress during cold air exposure. Ther Adv Cardiovasc Dis 7(3):123-129, 2013.
229. Holsworth R, Cho Y, Weidman J, Sloop G, St.Cyr, J. Cardiovascular benefits of phlebotomy: Relationship to changes in hemorheological variables. Perfusion 29(2):102-116, 2014.
230. St.Cyr JA, Khankari R, Addis PB. Compositions and methods for feeding poultry, USP8741854, 2014.
231. Shecterle LM, St.Cyr JA. Editorial: A potential role of D-ribose for myocardial diastolic dysfunction. J Card & Therapy 1(1):1-2, 2014.
232. Barka N, Grassl E, Phillips L, St.Cyr JA. Letter to the Editor. Anomalous right coronary arterial-aortic fistula in an adult sheep. Vet Surg 434(7):895-896, 2014.
233. Choudhuri I, MacCarter D, Shaw R, Anderson S, St. Cyr JA, Niazi I. Clinical feasibility of exercise-based A-V interval optimization for cardiac resynchronization: A pilot study. Pacing Clin Electrophysiol 37(11):1499-1509, 2014.
234. St.Cyr JA, Ericson DG, Johnson CA. Methods for rejuvenating, USP8759315, 2014.
235. Verlaan G, St.Cyr JA. Method and compositions for improving pulmonary hypertension, USP8835396, 2014.
236. Sloop G, Holsworth RE, Weidman JJ, St.Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther Adv Cardiovasc Dis 9(1):19-25, 2015.
237. Seifert JG, Frost J, ST.Cyr JA. The influence of a heat and moisture exchange mask on sprint performance in the cold. Int J Sports Physiol and Performance, 2014.
238. Sloop G, Weidman J, St.Cyr JA. Perspective: The failure of cholesteryl ester transfer protein inhibitors: is their failure due to increased blood viscosity? Ther Adv Cardiovasc Dis 9(2):32-35, 2015.
239. Rakow N, Barka N, Gerhart R, Grassl E, Green M, Rothstein P, Schu C, Kopcak M, Shecterle L, St.Cyr J. Chronic aortic root pressure-loading assessment model. Ther Adv Cardiovasc Dis 9(2):40-44, 2015.
240. Bayram M, St.Cyr J, Abraham W. D-ribose aids heart failure patients with preserved ejection fraction and diastolic dysfunction: A pilot study. Ther Adv Cardiovasc Dis 9:56-65, 2015.
241. Sloop G, Weidman J, Shecterle L, St.Cyr JA. The interplay of aging, aortic stiffness and blood viscosity in atherogenesis. J Card & Therapy 2(4):350-354, 2015.
242. Brumet A, Seifert JG, St.Cyr J. The influence of ribose ingestion on recovery and performance in healthy individuals. Med Sci in Sports and Exercise 47(Supplement 5S):336-343, 1295, Board #88, 2015.
243. Perkowski DJ, Wagner S, Muller K, Schneider JR, St.Cyr JA. Ten year experience of using a novel metabolic protocol in “off pump” coronary artery bypass revascularization. Ther Adv Cardiovasc Dis 9(6):336-341, 2015.
244. Shecterle LM, Terry KR, St.Cyr JA. Re-assessing red blood cell storage. Global J Med Clin Case Reports 2(1):115, 2015.
245. Sloop G, Weidman J, St.Cyr JA. Perspective: The systemic vascular resistance response: a cardiovascular response modulating blood viscosity with implications for primary hypertension and certain anemias. Ther Adv Cardiovasc Dis 9(6):403-411, 2015.
246. Addis P, St.Cyr JA. Editorial. Nutritional supplementation of donors may improve outcomes of transfusion of stored blood. Austin J Nutr & Metabolism 2(1):1015, 2015.
247. Sloop GD, Bialczak JK, Weidman JJ, St.Cyr JA. Uric acid increases erythrocyte aggregation: Implications for cardiovascular disease. Clinical Hemorheology and Microcirculation 63;349-359, 2016.
248. Barka N, Bourgoin J, Grassl E, St.Cyr J. Echocardiographic assessment of aortic valve annular and left ventricular outflow tract diameter in conscious and anesthetized adult sheep prior to prosthetic aortic valve implantation. Ther Adv Cardiovascular Dis 10(4):185-191, 2016.
249. Weidman JJ, Sloop GD, St.Cyr JA. Validated formulae for estimation of whole blood viscosity underestimates the influence of erythrocyte aggregation and deformability. Ther Adv Cardiovasc Dis 10(4):271-273, 2016.
250. Shecterle LM, St.Cyr JA. D-ribose in Ischemic Cardiovascular Disease. In: Handbook on Coronary Artery Disease. Rao, G HR (Ed). Springer Healthcare, New Delhi, India; 317-325, 2016.
251. Weidman J, Holsworth RE, Brossman B, Cho DJ, St.Cyr John, Fridman G. Effect of electrolyzed high-pH alkaline water on blood viscosity in healthy adults. J Internat Soc Sports Nutrition 13:45, 2016.
252. Addis PB & St.Cyr JA. Nutritional supplementation of donors may improve outcomes following the transfusion of stored red blood cells. J Diet Suppl 14(4):485-488, 2017.
253. Butler TL, St.Cyr J, Johnson CA. Composition and methods for improving cardiovascular function. USP9572882, 2017.
254. Sloop G & St.Cyr J. LDL is not the sole cause of atherosclerosis. Comment on the published article: Ference B et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38(16): pp, April 24, 2017.
255. Seifert JG, Frost J, St.Cyr JA. Recovery benefits of using a heat and moisture exchange mask during spring exercise in cold temperatures. SAGE Open Medicine; Vol 5:2050312117740985, 2017.
256. Sloop G, Weidman JJ, St.Cyr J. Atherothrombosis is a thrombotic, not an inflammatory disease. Cureus 9(12):e1909, 2017.
257. Seifert J, Brumet A, St.Cyr J. The influence of D-ribose ingestion and fitness level on performance and recovery. J Internat Soc Sports Nutrition 14:47, 2017.
258. Sloop G, Weidman J, St.Cyr J. Perspective: Interesterified triglycerides, the recent increase in deaths from heart disease and elevated blood viscosity. Ther Adv Cardiovasc Dis 12(1):23-28, 2018.
259. Shecterle LM, Terry KR, St.Cyr JA. Potential clinical benefits of D-ribose in ischemic cardiovascular disease. Cureus 10(3): e2291, 2018.
260. Sloop GD, Pop G, Weidman JJ, St.Cyr JA. Flawed reasoning allows the persistence of mainstream atherothrombosis theory. Cureus 10(3): e2377, 2018.
261. Sloop GD, Pop G, Weidman JJ, St.Cyr JA. Apolipoprotein(s) is the product of a Pseudogene: Implications for the pathophysiology of lipoprotein (a). Cureus 10(5):e2715, 2018.
262. Perkowski D, St.Cyr J, Xue A. D-ribose based protocol aids patients undergoing “off pump” coronary artery revascularization. JACC 72(16) supplement: C176, 2018.
263. Sloop GD, Gheorghe P, Weidman JJ, St.Cyr JA. Why atherothrombosis is in principle a hematologic disease: the effect of disorders and drugs which affect thrombosis on the development of atherosclerotic plaque. Int Arch Cardiovasc Dis 2:012.10.23937/iacvd-2017/1710012, 2019.
264. Bayram M, Perkowski D, St.Cyr JA, Abraham WT. Clinical significance and applications of D-riobse in cardiovascular disease. Int Arch Cardiovasc Dis 2:013.10.23937/iacvd-2017/17100B, 2019.
265. Sloop G, Pop G, Weidman, J, St.Cy rJ. Commentary response to an article by Ridken. The effect of successful anti-inflammatory therapy is mediated by decreased fibrinogen concentrations. Eur Heart J 39(45), 2019.

Join as a Editor